Host intestinal epithelium and immune system

The host intestinal epithelium and immune system represent a complex, integrated physiological unit responsible for maintaining a selective barrier between the external environment and the internal milieu. The epithelium provides a physical and biochemical shield, while the gut-associated lymphoid tissue (GALT) executes sophisticated immune surveillance to distinguish between harmless commensal microbes and potential pathogens (Nature Reviews Immunology, 2014; NCBI Bookshelf, 2023). Dysregulation of this system is a hallmark of chronic inflammatory conditions such as inflammatory bowel disease (IBD), where a breakdown in barrier function and an overactive immune response lead to persistent tissue damage (The Lancet, 2017). Therapeutic interventions often focus on specific molecular components within this system, such as cytokines or cell-adhesion molecules, to dampen inflammation and promote mucosal healing. Understanding the crosstalk between epithelial cells and immune cells is critical for developing targeted therapies that restore intestinal homeostasis without compromising systemic immunity (Science, 2021).

Other names

Gut-associated lymphoid tissueGALTIntestinal mucosal barrierIntestinal immune systemGut-immune axisMucosal immune system

Drugs interacting with this system typically function by neutralizing pro-inflammatory cytokines (e.g., TNF-alpha, IL-12/23), blocking lymphocyte trafficking to the intestinal mucosa (e.g., alpha-4 beta-7 integrin antagonism), or inhibiting intracellular signaling pathways like the JAK-STAT pathway to reduce chronic inflammation and promote mucosal healing (Nature Reviews Gastroenterology & Hepatology, 2020; Journal of Crohn's and Colitis, 2021).